Dalmases Massegú, A., González González, I., Menendez Romero, S., Arpí Llucià, O., Corominas Torres, J. M., Servitja Tormo, S., . . . Rojo, F. (2014). Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer.
Citación estilo ChicagoDalmases Massegú, Alba, et al. Deficiency in P53 Is Required for Doxorubicin Induced Transcriptional Activation of NF-κB Target Genes in Human Breast Cancer. 2014.
Cita MLADalmases Massegú, Alba, et al. Deficiency in P53 Is Required for Doxorubicin Induced Transcriptional Activation of NF-κB Target Genes in Human Breast Cancer. 2014.
Precaución: Estas citas no son 100% exactas.